Jack & Julia Center for TSC, Oakland Children's Hospital and Research Center — Oakland, California

Jack & Julia Center for TSC, Oakland Children's Hospital and Research Center is a clinical research site located in Oakland, California, United States.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Jack & Julia Center for TSC, Oakland Children's Hospital and Research Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Tuberous Sclerosis, Lymphangioleiomyomatosis.

Sponsors: National Tuberous Sclerosis Association.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Jack & Julia Center for TSC, Oakland Children's Hospital and Research Center?

Jack & Julia Center for TSC, Oakland Children's Hospital and Research Center has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Jack & Julia Center for TSC, Oakland Children's Hospital and Research Center conducted?

Jack & Julia Center for TSC, Oakland Children's Hospital and Research Center has 1 clinical trials on record, with 1 currently active. Their work covers Tuberous Sclerosis, Lymphangioleiomyomatosis.

Is Jack & Julia Center for TSC, Oakland Children's Hospital and Research Center accredited by Crixeo Health?

Jack & Julia Center for TSC, Oakland Children's Hospital and Research Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Jack & Julia Center for TSC, Oakland Children's Hospital and Research Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.